Circle Health Group joins forces with My Clinical Outcomes since May 2023 to introduce their Patient Recorded Outcomes Measures platform at each of Circle’s 54 hospitals.

A project with the Enhanced Supportive Care team to remotely collect quality of life data for cancer patients who may require palliative care input and provide them with additional support at an earlier stage.

Patient-reported outcomes analytics from across 39 hospitals including extracts to the Private Healthcare Information Network (PHIN) to meet regulatory requirements.

Funding from the Scottish Funding Council to develop a tailored solution for NHS Scotland cancer patients. Roll-out has started with haematology patients at NHS Ayrshire and Arran.

Digital PROMs introduced to learn more about the patient journey and how their treatment benefits them, whilst also monitoring any areas for improvement and meeting the industry's regulatory requirements.

Live since 2011, the platform has been used by orthopaedic surgeons to remotely monitor long-term outcomes data as part of ‘virtual clinic’ follow-up of hip and knee replacements. Helps to preserve outpatient clinic capacity.

In a unique collaboration with HCA Healthcare UK, MCO has developed a bespoke version of the platform to enable a direct data feed integration from HCA to MCO. By doing so, this has enabled numerous advantages that addresses some of the current challenges.

A research study to explore the ability of using remote, digital PROMs to enhance the care of patients with colorectal conditions undergoing surgery at Chelsea and Westminster NHS Foundation Trust.

MCO have partnered with Alliance Medial Limited (AML) through the GE Healthcare Edison Accelerator programme to implement routine outcomes measurement across the NHS PET / CT scanning service.

MCO, Macmillan Cancer Support and The Royal College of Radiologists collaborated on a partnership to understand the feasibility of using remote, digital PROMs to screen for potential long-term side effects (of "late effects") resulting from pelvic cancer radiotherapy treatment.